Jesper Folsted Kallehauge
Overview
Explore the profile of Jesper Folsted Kallehauge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
69
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasmussen M, Dueholm Vestergaard C, Folsted Kallehauge J, Ren J, Haislund Guldberg M, Norrevang O, et al.
Phys Imaging Radiat Oncol
. 2024 Jul;
31:100607.
PMID: 39071159
The use of and research in automation and artificial intelligence (AI) in radiotherapy is moving with incredible pace. Many innovations do, however, not make it into the clinic. One technical...
2.
Hasler S, Folsted Kallehauge J, Hansen R, Samsoe E, Arp D, Dahl Nissen H, et al.
Acta Oncol
. 2023 Oct;
62(11):1551-1560.
PMID: 37815867
Background: As magnetic resonance imaging (MRI) becomes increasingly integrated into radiotherapy (RT) for enhanced treatment planning and adaptation, the inherent geometric distortion in acquired MR images pose a potential challenge...
3.
Ahangari S, Andersen F, Hansen N, Nottrup T, Berthelsen A, Folsted Kallehauge J, et al.
Eur J Hybrid Imaging
. 2022 Apr;
6(1):7.
PMID: 35378619
Aim: The concept of personalized medicine has brought increased awareness to the importance of inter- and intra-tumor heterogeneity for cancer treatment. The aim of this study was to explore simultaneous...
4.
A national study on the inter-observer variability in the delineation of organs at risk in the brain
Lorenzen E, Folsted Kallehauge J, Skinnerup Byskov C, Dahlrot R, Aaquist Haslund C, Guldberg T, et al.
Acta Oncol
. 2021 Oct;
60(11):1548-1554.
PMID: 34629014
Background: The Danish Neuro Oncology Group (DNOG) has established national consensus guidelines for the delineation of organs at risk (OAR) structures based on published literature. This study was conducted to...
5.
Haldbo-Classen L, Amidi A, Lukacova S, Wu L, Von Oettingen G, Lassen-Ramshad Y, et al.
Radiother Oncol
. 2020 Apr;
148:1-7.
PMID: 32298906
Background: Radiation therapy (RT) to the brain may result in cognitive impairment. The primary objective of the present study was to examine the relationship between RT dose to the hippocampus...
6.
Haack S, Tanderup K, Folsted Kallehauge J, Mohamed S, Lindegaard J, Pedersen E, et al.
Acta Oncol
. 2015 Jul;
54(9):1535-42.
PMID: 26217984
Background: Diffusion-weighted magnetic resonance imaging (DW-MRI) and the derived apparent diffusion coefficient (ADC) value has potential for monitoring tumor response to radiotherapy (RT). Method used for segmentation of volumes with...
7.
Vestergaard A, Folsted Kallehauge J, Petersen J, Hoyer M, Sondergaard J, Paul Muren L
Radiother Oncol
. 2014 Aug;
112(3):371-5.
PMID: 25150634
Purpose: Adaptive radiotherapy (ART) has considerable potential in treatment of bladder cancer due to large inter-fractional changes in shape and size of the target. The aim of this study was...
8.
Folsted Kallehauge J, Tanderup K, Duan C, Haack S, Pedersen E, Lindegaard J, et al.
Acta Oncol
. 2014 Jul;
53(8):1064-72.
PMID: 25034348
Background: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) offers a unique capability to probe tumour microvasculature. Different analysis of the acquired data will possibly lead to different conclusions. Therefore, the objective...
9.
Folsted Kallehauge J, Tanderup K, Haack S, Nielsen T, Paul Muren L, Fokdal L, et al.
Acta Oncol
. 2010 Sep;
49(7):1017-22.
PMID: 20831490
Background: Diffusion weighted imaging (DWI) has gained interest as an imaging modality for assessment of tumor extension and response to cancer treatment. The purpose of this study is to assess...